| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | Chief Financial Officer | Common Stock | 65,767 | 20 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PHASQ | PhaseBio Pharmaceuticals Inc | 20 May 2022 | 1 | +$4,106 | 4 | Chief Financial Officer | 24 May 2022, 17:12 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 24 Feb 2022 | 2 | $0 | 4 | Chief Financial Officer | 28 Feb 2022, 18:30 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 19 Nov 2021 | 1 | +$4,054 | 4 | Chief Financial Officer | 23 Nov 2021, 17:53 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 03 Nov 2021 | 2 | $0 | 4 | Chief Financial Officer | 03 Nov 2021, 19:30 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 03 Aug 2021 | 2 | +$12,600 | 4/A | Chief Financial Officer | 03 Sep 2021, 16:41 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 20 May 2021 | 1 | +$3,973 | 4 | Chief Financial Officer | 24 May 2021, 18:11 |